Th1/Th2 cytokine responses following HIV-1 immunization in seronegative volunteers

Clinical and Experimental Immunology

Volumn 111, Issue 2, 1998, Pages 243-250

  Evans, T G ^a,b   Fitzgerald, T ^a   Gibbons, D C ^a   Keefer, M C ^a   Soucier, H ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b Infectious Diseases Unit   (United States)

Author keywords

Cytokines; HIV 1; Immunization; Th1 Th2

Indexed keywords

ADJUVANT; ALUMINUM HYDROXIDE; CANDIDA ANTIGEN; CYTOKINE; GAMMA INTERFERON; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INFLUENZA VACCINE; INTERLEUKIN 10; INTERLEUKIN 4; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINYLALANYL DIPALMITOYLPHOSPHATIDYLETHANOLAMINE; PHORBOL 13 ACETATE 12 MYRISTATE; PHYTOHEMAGGLUTININ; PLACEBO; RECOMBINANT VACCINE; TETANUS TOXOID;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MARKER; HELPER CELL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNIZATION; IMMUNOSTIMULATION; IMMUNOTHERAPY; INTERFERON PRODUCTION; INTRAMUSCULAR DRUG ADMINISTRATION; MONONUCLEAR CELL; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; PRACTICE GUIDELINE; PRIORITY JOURNAL;

EID: 0031910784     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00486.x     Document Type: Article

References (50)

1. Cease KB, Berzofsky JA. Toward a vaccine for AIDS: the emergence of immunobiology-based vaccine development. Annu Rev Immunol 1994; 12:923-89.
2. Sztein MB, Wasserman SS, Tacket CO et al. Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi. J Infect Dis 1993; 170:1508-17.
3. Sander B, Skansen-Saphir U, Damm O, Hakansson L, Andersson J, Andersson U. Sequential production of Th1 and Th2 cytokines in response to live bacillus Calmette-Guérin. Immunology 1995; 86:512-8.
4. Ward BJ, Griffin DE. Changes in cytokine production after measles virus vaccination: predominant production of IL-4 suggests induction of a Th2 response. Clinic Immunol Immunopathol 1993; 67:171-7.
5. Romagnani S. Induction of TH1 and Th2 responses: a key role for the 'natural' immune response. Immunol Today 1992; 13:379-81.
6. Yamamura M, Uyemura K, Deans RJ et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991; 254:277-9.
7. Heinzel FP, Sadick MD, Holaday BJ et al. Reciprocal expression of interferon gamma and interleukin 4 during the resolution or progression of murine leishmaniasis. J Exp Med 1989; 169:59-72.
8. Kanagawa O, Vaupel BA, Gayama S et al. Resistance of mice deficient in IL-4 to retrovirus induced immunodeficiency syndrome (MAIDS). Science 1993; 262:2402-4.
9. Urban JF, Katona IM, Paul WE et al. Interleukin 4 is important in protective immunity to a gastrointestinal nematode infection in mice Proc Natl Acad Sci USA 1991; 88:5513-7.
10. Locksley RM. Th2 cells: help for helminths. J Exp Med 1994; 179:1405-7.
11. Bretscher PA, Wei G, Menon JN, Bielefeldt-Ohmann H. Establishment of stable, cell mediated immunity that makes 'susceptible' mice resistant to Leishmania major. Science 1992; 257:539-42.
12. + positive lymphocytes in IFN-gamma production and protective immunity induced by attenuated Toxoplasma gondii vaccine. J Immunol 1991; 146:286-92.
13. Finkelman FD, Holmes J, Katona IM et al. Lympokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 1990; 8:303-33.
14. Mossman TR, Cherwinski H, Bond MW et al. Two types of murine helper T cell clone 1. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136:2348-57.
15. Clerici M, Stocks NI, Zajac RA et al. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. J Clin Invest 1989; 84:1892-9.
16. Maggi E, Mazzetti M, Ravina A et al. Ability of HIV to promote a TH1 to THO shift and to replicate preferentially in TH2 and TH0 cells. Science 1994; 265:244-8.
17. Clerici M, Hakim FT, Venzon DJ et al. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest 1993; 91:759-65.
18. Shearer GM, Clerici M. Protective immunity against HIV infection: has nature done the experiment for us? Immunol Today 1996; 17:21-24.
19. Clerici M, Giorgi JV, Chou C-C et al. Cell mediated immune response to human immunodeficiency virus type 1 (HIV-1) in seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis 1992; 165:101-9.
20. Finkelman FD. Relationships among antigen presentation, cytokines, immune deviation, and autoimmune disease. J Exp Med 1995; 182:279-82.
21. Romagnani S. The biology of human TH1 and TH2 cells. J Clin Immunol 1995; 15:121-9.
22. Xu-Amano J, Kiyono H, Jackson RJ et al. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J Exp Med 1993; 178:1309-20.
23. Tang Y-W, Graham BS. Potential for directing appropriate responses to vaccine by cytokine manipulation. Clin Immunother 1996; 6:1-7.
24. DelPrete GF, DeCarli M, Mastromauro C, Biagiotti R, Macchia D, Falagiani P, Ricci M, Romagnani S. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest 1991; 88:346-50.
25. + T cells. I. Influence of antigen concentration and antigen-presenting cell type. J Immunol 1992; 149:3468-76.
26. + T cells. Ann Rev Immunol 1994; 12:635-73.
27. Barnard A, Mahon BP, Watkins J, Redhead K, Mills KHG. Th1/Th2 dichotomy in acquired immunity to Bordetella pertussis: variability in the in vivo priming and in in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2, or Th0. Immunology 1996; 87:372-80.
28. Imada M, Estelle F, Simons R, Jay FT, HayGlass KT. Antigen-mediated and polyclonal stimulation of human cytokine production elicit qualitatively different patterns of cytokine gene expression. Int Immunol 1995; 7:229-37.
29. Street BE, Schumacher JH, Fong TA et al. Heterogeneity of mouse helper T cells. Evidence from bulk cultures and limiting dilution cloning for precursors of Th1 and Th2 cells. J Immunol 1991; 144:1629-39.
30. + T cells requires repeated antigenic stimulation. Cell Immunol 1993; 152:18-34.
31. + T cells from allergic individuals. J Exp Med 1993; 178:2123-30.
32. + subsets. J Immunol 1995; 155:3322-8.
33. Daynes RA, Araneo BA. Natural regulators of T-cell lymphokine production in vivo. J Immunother 1992; 12:174-9.
34. Mocci S, Coffman RL. Induction of a Th2 population from a polarized Leishmania-specific Th1 population with in vitro culture with IL-4. J Immunol 1995; 154:3779-87.
35. + T cells from T cell receptor transgenic mice. J Exp Med 1992; 176:1091-8.
36. Gajewski TF, Fitch FW. Anti-proliferative effect of IFN-γ in immune regulation I. IFN-γ inhibits the proliferation of Th2 but not Th1 murine helper T cell clones. J Immunol 1988; 140:4245-52.
37. Fernandez-Botran R, Sanders VM, Mossman TR, Vitetta ES. Lymphokine-mediated regulation of the proliferative response of clones of T helper 1 and T helper 2 cells. J Exp Med 1988; 168:543-58.
38. Keefer MC, Graham BS, McElrath MJ et al. Safety and immunogenicity of Env 2-3, a human immunodeficiency virus type I candidate vaccine, in combination with a novel adjuvant. MTP-PE/MF59. AIDS Res Human Retrovir 1996; 12:683-93.
39. Keefer MC, Bonnez W, Roberts NJ Jr et al. Human immunodeficiency virus (HIV-1) gp160-specific lymphocyte proliferative responses of mononuclear leukocytes from HIV-1 recombinant gp160 vaccine recipients. J Infect Dis 1991; 163:448-53.
40. Phelan MA, Mayner RE, Bucher DJ, Ennis FA. Purification of influenza virus glycoproteins for the preparation and standardization of immunological potency testing reagents. J Biol Standard 1980; 8:233-42.
41. Spruance SL, Evans TG, McKeough M, Thai L, Mishkin E, Abramovitz A. Correlation of herpes virus-specific cellular immunity with susceptibility and severity of herpes simplex labialis. Antiviral Res 1995; 28:39-55.
42. Roederer M, Dubs JG, Anderson MT, Raju PA, Herzenberg LA, Herzenberg LA. CD8 naive T cells decrease progressively in HIV-infected adults. J Clin Invest 1995; 95:2061-6.
43. Kanegane H, Kashara Y, Niida Y et al. Expression of L-selectin (CD62L) discriminates Th1- and Th2-like cytokine-producing memory T cells. Immunology 1996; 87:186-90.
44. Bradley LM, Croft M, Swain SL. T cell memory: new perspectives. Immunol Today 1993; 14:197-9.
45. Holaday BJ, Pompeu MMdeL, Evans TG et al. Correlates of Leishmania-specific immunity in the clinical spectrum of infection with Leishmania chagasi. J Infect Dis 1993; 167:411-7.
46. Jutel M, Pichler WJ, Skrbic D, Urwyler A, Dahinden C, Müller UR. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen-stimulated T cell cultures. J Immunol 1995; 154:4187-94.
47. Menon JN, Bretscher PA. Characterization of the immunological memory state generated in mice susceptible to Leishmania major following exposure to low doses of L. major and resulting in resistance to a normally pathogenic challenge. Eur J Immunol 1996; 26:243-9.
48. Zhang X, Brunner T, Carter C et al. Unequal death in T helper cell (Th1 and Th2) effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J Exp Med 1997; 185:1837-49.
49. Varadhachary AS, Perdow SN, Hu C, Ramananrayan M, Salgame P. Differential ability of T cell subsets to undergo activation-induced cell death. Proc Natl Acad Sci USA 1997; 94:5578-83.
50. + T-cell clones with different T-helper phenotypes: a role of CD95/ CD95L interactions. Blood 1997; 89:558-69.